Filter
203
Filtered Results: 203
Text search:
Breakthrough
ACTION
et
al.
Featured
Recommendations
21
New Publications
36
Language
Document type
No document type
92
Studies & Reports
48
Guidelines
35
Manuals
14
Training Material
5
Strategic & Response Plan
3
Fact sheets
3
Situation Updates
1
Resource Platforms
1
Infographics
1
Countries / Regions
Global
11
Ethiopia
7
India
7
South Africa
5
Western and Central Europe
4
Kenya
3
Syria
3
USA
3
Asia
3
Tanzania
3
Russia
3
Sierra Leone
2
Africa
2
Congo, Democratic Republic of
2
South–East Asia Region
2
Tajikistan
1
Nepal
1
Ukraine
1
Ghana
1
Nigeria
1
Laos
1
Senegal
1
Malawi
1
Guinea
1
Mozambique
1
Venezuela
1
Latin America and the Carribbean
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Côte d’Ivoire / Ivory Coast
1
Vietnam
1
Uganda
1
Eastern Europe
1
Brazil
1
Sri Lanka
1
Namibia
1
Yemen
1
Mali
1
Chad
1
Botswana
1
Iraq
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
48
Clinical Guidelines
22
Key Resources
13
Women & Child Health
11
Public Health
7
Capacity Building
5
Pharmacy & Technologies
2
Toolboxes
COVID-19
28
HIV
23
NTDs
14
TB
12
Planetary Health
10
Mental Health
8
Malaria
8
AMR
8
Global Health Education
7
Health Financing Toolbox
6
Conflict
6
Caregiver
5
Rapid Response
4
Disability
4
Specific Hazards
3
Natural Hazards
3
Refugee
2
Ebola & Marburg
2
Polio
2
Social Ethics
1
Pharmacy
1
Zika
1
first issued 18 August 2022
The report shows that where people and communities living with and affected by HIV are engaged in decision-making and HIV service delivery, new infections decline and more people living with HIV gain access to treatment. When people have the power to choose, to know, to thrive, to demand and to work...
Considerations for implementing and adjusting public health and social measures in the context of COVID-19
recommended
interim guidance, 14 June 2021
This document is intended for national authorities and decision makers in countries that have introduced large scale public health and social measures. It offers guidance for adjusting public health and social measures, while managing the risk of a resurgence of cases...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
Acclerating attainment of universal health coverage and bridging the access inequity gap
Fact Sheet Global Atlas of medical devices
The International Association for Child and Adolescent Psychiatry and
Allied Professions (IACAPAP) aims to promote the mental health and
development of children and adolescents worldwide. It seeks to achieve
this by contributing to the training and professional development of the
child and adole...
Religion and Development 01/2019. Discussion Paper Series of the Research Programme on Religious Communities and Sustainable Development
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses
an approach to optimize the global impact of COVID-19 vaccines, based on public health goals, global and national equity, and vaccine access and coverage scenarios, first issued 20 October 2020, updated: 13 November 2020, updated: 16 July 2021, latest update: 21 January 2022
Available in English, F...
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be u...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
3rd edition!
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
DHS Further Analysis Reports No. 103
Technical and operational ‘how-to’: practical considerations
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
